Addiction Drug Developer Adial Pharmaceuticals Successfully Passes Patent Opposition Period in Europe for AD04 in …

  1. Addiction Drug Developer Adial Pharmaceuticals Successfully Passes Patent Opposition Period in Europe for AD04 in …  The Bakersfield Californian

  2. Adial Pharmaceuticals (ADIL) Reports ‘No Challenges to European Patent’ for AD04 in Alcohol Use Disorder  StreetInsider.com

    3. Full coverage